Chiron Investment Management, LLC Repligen Corp Transaction History

Chiron Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $493,157 - $820,899	-2,532 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $285,794 - $380,696	1,723 Added 212.98%	2,532 $505,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $119,796 - $167,115	809 New	809 $155,000

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.82B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Investment Management, LLC with notifications on news.